Package 69102-639-09

{"route": ["ORAL"], "spl_id": "f193d1ef-b995-4952-90dd-f2c1c0df3480", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["198427", "282401", "751139", "751563", "753451"], "spl_set_id": ["474fb321-575c-4b97-9dbe-080061652ee4"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["OWP Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "35 TABLET in 1 DOSE PACK (69102-639-09)", "package_ndc": "69102-639-09", "marketing_start_date": "20170830"}], "brand_name": "LAMOTRIGINE", "product_id": "69102-639_f193d1ef-b995-4952-90dd-f2c1c0df3480", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "69102-639", "generic_name": "LAMOTRIGINE", "labeler_name": "OWP Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LAMOTRIGINE", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA078947", "marketing_category": "ANDA", "marketing_start_date": "20170830", "listing_expiration_date": "20261231"}